Cargando…
Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
Patients with advanced-stage natural killer/T-cell lymphoma (NKTCL) usually have a poor prognosis. However, there is limited data of comprehensive analysis on this particular patient population due to the rarity of the disease. The present study aimed to investigate the treatment models, survival ou...
Autores principales: | Liu, Weiping, Yang, Yong, Qi, Shunan, Wang, Ying, He, Xia, Zhang, Liling, Qu, Baolin, Qian, Liting, Hou, Xiaorong, Qiao, Xueying, Wang, Hua, Li, Gaofeng, Zhang, Yujing, Zhu, Yuan, Cao, Jianzhong, Wu, Junxin, Wu, Tao, Zhu, Suyu, Shi, Mei, Xu, Liming, Su, Hang, Lin, Ningjing, Zhu, Jun, Li, Yexiong, Song, Yuqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945040/ https://www.ncbi.nlm.nih.gov/pubmed/33718104 http://dx.doi.org/10.3389/fonc.2020.583050 |
Ejemplares similares
-
Immune checkpoint inhibitors in malignant lymphoma: Advances and perspectives
por: Lin, Ningjing, et al.
Publicado: (2020) -
Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation
por: Qi, Fei, et al.
Publicado: (2022) -
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group
por: Hong, Huangming, et al.
Publicado: (2020) -
Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma
por: Liu, Weiping, et al.
Publicado: (2023) -
Characteristics and prognosis of distant metastasis after primary treatment for early‐stage extranodal nasal‐type natural killer/T‐cell lymphoma from the China Lymphoma Collaborative Group database
por: Zheng, Xuan, et al.
Publicado: (2022)